Jula Inrig, CHIEF MEDICAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 8,233 shares at $41.93 ($346K) on 2026-04-14, disclosed to the SEC on 2026-04-15.
Scheduled sale ($346k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.93 | 7,215 | $303K | 87.5% |
| 2 | $42.61 | 1,018 | $43K | 12.5% |
| Total | $42.01 avg | 8,233 | $346K | 100% |
| Filing → |
| TVTX | SELL | 2026-02-05 | $57K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $223K | — | Filing → |
| TVTX | SELL | 2026-01-07 | $98K | — | Filing → |